Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Diageo's sell-off marks attractive buying opportunity, says Citi

(Sharecast News) - Diageo's stock was attempting a rebound on Wednesday after a sell-off the previous session as its full-year results disappointed, but that didn't stop Citi from reiterating its 'buy' recommendation on the stock. Citi upgraded Diageo from 'neutral' on 3 July on the back of positive earnings momentum going into the new financial year - something which the bank still believes.

The results for the year ended 30 June 2024, which were met with a 5% share-price fall after a 1.4% decline in net sales and a 5% fall in organic operating profit, has acted as a "clearing event" for shareholders, Citi says.

"Downgrades to the FY25 consensus are in excess of the c.-5% we think the market was braced for ahead of Diageo's FY24 results. However, the stock rallied from its early results day share price lows to finish down just c.5%. This reaction reinforces our view that, like us, investors are viewing these results as a clearing event," the bank said in a research report.

While a cautious outlook from management has prompted Citi to trim its organic growth estimates for the current year - with the stock's target price coming down accordingly to 2,900p from 3,000p - "we believe this is the final downgrade for Diageo".

"With earnings/valuations metrics troughing and scope for H2 25 organic growth to accelerate as the group laps through destocked comps, we think it is time to revisit what remains an attractive compounding mid-term growth story. We reiterate our 'buy' rating."

Diageo's stock was up 2% at 2,466.5p by 0842 BST.

Share this article

Related Sharecast Articles

Auction Technology Group lowers full-year guidance as CFO steps down
(Sharecast News) - Auction Technology Group said it expects full-year revenues to be slightly shy of earlier guidance as it announced the resignation of its chief financial officer.
GSK to pay $2.2bn to settle Zantac lawsuits
(Sharecast News) - GSK has agreed to pay $2.2bn to settle about 80,000 Zantac lawsuits in the US.
Tritax EuroBox accepts Brookfield £557m offer as Segro trumped
(Sharecast News) - Canadian investment form Brookfield has trumped Segro's effort to buy warehouse owner Tritax EuroBox with an agreed £557m offer.
Thursday preview: US CPI, ECB minutes in the spotlight
(Sharecast News) - All eyes on Thursday will be on the week's key data release, the US consumer price index for the month of September.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.